First WHO Global Ministerial Conference; Ending tuberculosis in the sustainable development era: A multisectoral response; 16 -17 November 2017 Moscow, Russian Federation

First WHO Global Ministerial Conference on ending TB in the Sustainable Development Era

WHO holds the first Ministerial Conference "Ending Tuberculosis in the Sustainable Development Era: A Multisectoral Response" in Moscow, Russia, on 16-17 November 2017. The conference, hosted by the Ministry of Health of the Russian Federation aims to accelerate country implementation of the WHO End TB Strategy in order to reach the End TB targets. The Ministerial Conference will inform the UN General Assembly High-Level Meeting on TB to take place in 2018. Tuberculosis which remains the leading cause of death among people living with HIV, accounting for over one in three AIDS-related deaths.

#IASYouthVoices: What is Differentiated Care?

Call for examples of differentiated ART delivery for key populations

September 2017 - WHO, the International AIDS Society and other stakeholders are currently developing a decision framework to support the implementation and scale-up of differentiated service delivery for key populations. Differentiated service delivery is an approach that simplifies and adapts HIV services to better serve the needs of people living with or at risk of acquiring HIV and reduce unnecessary burdens on the health system.

Young boy smiling into the camera

WHO welcomes landmark agreement on first affordable, generic, single-pill HIV treatment regimen containing dolutegravir

21 September 2017 – Global partners announced breakthrough pricing agreement today to enable access to new, high-quality HIV treatment based on dolutegravir. WHO Director-General, Dr. Tedros Adhanom stated, "WHO welcomes this agreement which will make it possible to reach millions of people with better, more affordable and durable HIV drugs. This will save lives for the most vulnerable, bringing the world closer to the elimination of HIV."

Statement on HIV testing services

Statement on HIV testing services

28 August 2017 – HIV testing services are an essential gateway to HIV prevention, treatment, care and support services. WHO and UNAIDS endorse and encourage universal access to knowledge of HIV status. At the end of 2016, approximately 30% of people living with HIV were still unaware of their HIV status. Young people aged 15-24, adult males and people from key populations often have significantly lower access to HIV testing services, are less likely to be linked to treatment and care and have lower levels of viral suppression.

A man promotes HIV/AIDS awareness in Sector-11 of Chandigarh, India, on the eve of World Aids Day.

WHO urges action against HIV drug resistance threat

20 July 2017 – The World Health Organization alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries. The Organization warns that this growing threat could undermine global progress in treating and preventing HIV infection if early and effective action is not taken.

Pradeep Tewari, Courtesy of Photoshare
Children playing on the street

IAS and WHO identify the most critical research needs for infants, children and adolescents living with HIV

23 July 2017 | Paris, France – The most pressing gaps in research needed to improve outcomes for children and adolescents living with HIV are highlighted in the first global priority research agendas on paediatric and adolescent HIV, released at the 9th IAS Conference on HIV Science (IAS 2017) today. The new guidance was developed by the IAS’s Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) and WHO.

Sydelle Willow Smith

fact buffet

People living with HIV

36.7 million There were approximately 36.7 million people living with HIV at the end of 2016.

For more: Data and statistics

People on antiretroviral therapy

19.5 millionIn 2016, 19.5 million people living with HIV were receiving ART globally.

For more: HIV/AIDS fact sheet

Mother-to-child transmission

7 out of 107 out of 10 pregnant women living with HIV received antiretroviral treatment.

For more: Data and statistics

In focus: HIV drug resistance

HIV drug resistance develops when people do not adhere to a prescribed treatment plan, often because they do not have consistent access to quality HIV treatment and care. Increasing HIV drug resistance trends could lead to more infections and deaths, and undermine global progress in treating and preventing HIV infection if early and effective action is not taken.


Towards ending AIDS by 2030

Global health sector strategy on HIV, 2016-2021

The Global health sector strategy on HIV, 2016-2021, outlines what countries need to do and what WHO will do to achieve the ambitious target of the 2030 Sustainable Development Agenda.

Stay connected

WHO, Department of HIV

Sign-up for newsletters

Register in our Stakeholders’ database by sending an email to hiv-aids[at] with subject line “Sign-up for newsletters”. You will receive regular updates from our Department.